Results 11 to 20 of about 68,105 (186)

Interactions between Avibactam and Ceftazidime-Hydrolyzing Class D β-Lactamases [PDF]

open access: yesBiomolecules, 2020
Class D β-lactamases exhibit very heterogeneous hydrolysis activity spectra against the various types of clinically useful β-lactams. Similarly, and according to the available data, their sensitivities to inactivation by avibactam can vary by a
Jean-Marie Frère   +6 more
doaj   +2 more sources

Mechanisms of synergistic antibacterial and anti-biofilm effects of dihydroquercetin combined with ceftazidime against mucoid pseudomonas aeruginosa [PDF]

open access: yesFrontiers in Microbiology
ObjectiveThis study characterized the synergistic activity of dihydroquercetin combined with ceftazidime (CAZ) against mucoid Pseudomonas aeruginosa (mPA).
Li Gao   +4 more
doaj   +2 more sources

Refractory Retroperitoneal Abscess Caused by Hypermucoviscous Klebsiella pneumoniae Requiring Open Surgical Drainage [PDF]

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Klebsiella pneumoniae is broadly classified into classical and hypervirulent pathotypes, with the latter associated with invasive infections and hematogenous dissemination. Case Presentation An 89‐year‐old woman presented with fever and fatigue. Imaging revealed a large retroperitoneal abscess.
Shota Kikuchi   +9 more
wiley   +2 more sources

Feasibility, Effectiveness and Safety of Elastomeric Pumps for Delivery of Antibiotics to Adult Hospital Inpatients—A Systematic Review

open access: yesAntibiotics, 2023
Elastomeric infusion pumps (EMPs) have been implemented in many fields, including analgesia, chemotherapy and cardiology. Their application in antimicrobials is mainly limited to the outpatient setting, but with a need to optimise inpatient antimicrobial
Joseph Spencer-Jones   +3 more
doaj   +1 more source

Antibacterial Susceptibility Pattern of S. maltophilia Isolates at A Tertiary Care Hospital, India

open access: yesJournal of Pure and Applied Microbiology, 2023
A sudden emergence of Stenotrophomonas maltophilia as a primary pathogen both in immunocompromised and immunocompetent individuals has raised a serious concern, as it is associated with significant case fatality ratio.
Mohammed Ashraf Ali Namaji   +4 more
doaj   +1 more source

Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem

open access: yesVirulence, 2020
Patients with Acinetobacter baumannii bacteremia treated with antipseudomonal cephalosporins showed higher 14-day mortality than patients treated with antipseudomonal carbapenems.
Chun-Hsiang Chiu   +9 more
doaj   +1 more source

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex.

open access: yes, 2023
Pseudomonas aeruginosa causes a wide range of severe infections. Ceftazidime, a cephalosporin, is a key antibiotic for treating infections but a significant proportion of isolates are ceftazidime-resistant.
Winstanley, Craig   +15 more
core   +1 more source

Microbiological assay for ceftazidime injection

open access: yes, 2007
A simple, sensitive, and specific biodiffusion assay for the! antibacterial ceftazidime was developed using a strain of Staphylococcus epidermidis (ATCC 12228) as the test organism.
Salgado, Hérida Regina Nunes   +1 more
core   +4 more sources

Antimicrobial Effect of Zinc Oxide Nanoparticles against Multidrug-Resistant Acinetobacter baumannii

open access: yesJournal of Medical Microbiology and Infectious Diseases, 2023
Introduction: Increased multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) infections pose a significant challenge in hospital settings.
Nader Mashayekh1   +3 more
doaj   +1 more source

Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections [PDF]

open access: yes, 1983
Thirty-six urological patients (21 male, 15 female) aged 21 to 83 years with complicated and/or hospital-acquired urinary tract infections due to sensitive bacteria were treated with ceftazidime intravenously with a daily dose of 2 g bd over 5 to 17 days.
Kurt G. Naber   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy